BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 1971206)

  • 1. Cardiac hypertrophy in hypertension.
    Cífková R; Frídl P; Skibová J; Niederle P; Widimský J
    Cor Vasa; 1990; 32(1):3-12. PubMed ID: 1971206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with essential hypertension.
    Widimský J
    Cor Vasa; 1990; 32(1):1-2. PubMed ID: 1971205
    [No Abstract]   [Full Text] [Related]  

  • 3. Heart and vessel hypertrophy in hypertension: possibilities of regression.
    Cífková R; Niederle P; Romanovská L; Skibová J; Frídl P; Skalická H; Widimský J
    J Hypertens Suppl; 1987 Dec; 5(5):S407-10. PubMed ID: 2965227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regression of left heart hypertrophy in arterial hypertension: principles, experimental and clinical findings].
    Klaus D
    Z Kardiol; 1985; 74 Suppl 7():153-69. PubMed ID: 2936016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regression of hypertrophy following nitrendipine: effect on systolic and diastolic function].
    Vogt M; Kreutz KU; Motz W; Strauer BE
    Z Kardiol; 1989 Jul; 78(7):469-77. PubMed ID: 2528245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regression of hypertension-induced left heart enlargement in an endurance athlete treated with verapamil RR].
    Lehmann M; Dürr H; Keul J
    Z Kardiol; 1989 Jul; 78(7):465-8. PubMed ID: 2528244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy regression in hypertensive patients treated with metoprolol.
    Corea L; Bentivoglio M; Verdecchia P; Provvidenza M; Motolese M
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):365-70. PubMed ID: 6236155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Regression of left heart hypertrophy in hypertensive patients as a result of antihypertensive therapy].
    Franz IW; Tönnesmann U; Behr U; Ketelhut R
    Z Kardiol; 1989; 78 Suppl 5():43-8. PubMed ID: 2561036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Regression of hypertensive heart hypertrophy caused by chronic angiotensin-converting enzyme inhibition].
    Motz W; Strauer BE
    Z Kardiol; 1988 Jan; 77(1):53-60. PubMed ID: 2834885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of coronary insufficiency during prolonged treatment of essential hypertension.
    Kalnins UV; Skarda IJ; Liepinja DJ; Vitols AV
    Cor Vasa; 1990; 32(1):64-71. PubMed ID: 2140319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chronology of regression of hypertensive ventricular hypertrophy during antihypertensive therapy with beta blockers].
    Sau F; Seguro C; Pargentino E
    Cardiologia; 1994 Jul; 39(7):473-9. PubMed ID: 7982244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of left ventricular hypertrophy from systemic hypertension by gallopamil.
    Franz IW; Behr U; Ketelhut R; Agrawal B
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S178-81. PubMed ID: 2455127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of regression of left ventricular hypertrophy in treated hypertensive patients.
    Wollam GL; Hall WD; Porter VD; Douglas MB; Unger DJ; Blumenstein BA; Cotsonis GA; Knudtson ML; Felner JM; Schlant RC
    Am J Med; 1983 Sep; 75(3A):100-10. PubMed ID: 6226186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of indenolol on left ventricular mass in patients with essential arterial hypertension].
    Sau F; Seguro C; Lai C; Orani E; Soro A; Onnis E; Cherchi A
    Cardiologia; 1990 Nov; 35(11):925-30. PubMed ID: 2151570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Echocardiographic observations of hypertensive heart disease: a follow-up study].
    Takahashi H
    J Cardiogr; 1982 Dec; 12(4):953-61. PubMed ID: 6224867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of single-dose methyldopa and diuretic on BP and left ventricular mass.
    Weinstein M; Hilewitz H; Rogel S
    Arch Intern Med; 1984 Aug; 144(8):1629-32. PubMed ID: 6235790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of left ventricular hypertrophy by terazosin in hypertensive patients.
    Yasumoto K; Takata M; Yoshida K; Mikawa M; Tomoda F; Sasayama S
    J Hum Hypertens; 1990 Feb; 4(1):13-8. PubMed ID: 1971654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of four antihypertensive monotherapies on cardiac mass and function in hypertensive patients with left ventricular hypertrophy: randomized prospective study.
    Rakić D; Rumboldt Z; Bagatin J; Polić S
    Croat Med J; 2002 Dec; 43(6):672-9. PubMed ID: 12476475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
    Suzuki H; Kanno Y; Kaneko K; Kaneko M; Kotaki S; Mimura T; Takane H
    Ther Apher Dial; 2004 Aug; 8(4):320-7. PubMed ID: 15274684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible regression of left ventricular hypertrophy during antihypertensive treatment with diuretics and/or beta blockers.
    Cherchi A; Sau F; Seguro C
    J Clin Hypertens; 1987 Jun; 3(2):216-25. PubMed ID: 2886561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.